Journal article
Missing Anticitrullinated Protein Antibody Does Not Affect Short-term Outcomes in Early Inflammatory Arthritis: From the Canadian Early Arthritis Cohort.
Abstract
OBJECTIVE: Anticitrullinated protein antibody (ACPA) is as sensitive as, but more specific than, rheumatoid factor (RF) and is detected earlier in rheumatoid arthritis (RA). Although part of the RA classification criteria, ACPA testing is not routinely paid for/accessible in all jurisdictions. The effect of missing ACPA testing was studied to determine whether failure to perform ACPA testing could cause a care gap in early inflammatory …
Authors
Shu J; Bykerk VP; Boire G; Haraoui B; Hitchon C; Thorne JC; Tin D; Keystone EC; Pope JE
Journal
The Journal of Rheumatology, Vol. 42, No. 11, pp. 2023–2028
Publisher
The Journal of Rheumatology
Publication Date
November 2015
DOI
10.3899/jrheum.150260
ISSN
0315-162X
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
AdolescentAdultAgedAged, 80 and overAnalysis of VarianceAntibodies, Anti-IdiotypicAntirheumatic AgentsArthritis, RheumatoidCanadaChi-Square DistributionCohort StudiesDose-Response Relationship, DrugDrug Administration ScheduleFemaleFollow-Up StudiesHumansLogistic ModelsMaleMiddle AgedOdds RatioPeptides, CyclicProspective StudiesRheumatoid FactorSeverity of Illness IndexTime FactorsTreatment OutcomeYoung Adult